(The third, Foundayo, just got FDA approval in April, so its too new for spending data.) In 2024, Medicare spent over $19.3 billion on Ozempic and Mounjaro, according to gross spending data from CMS
Prescott-Allen and Prescott-Allen, 1990)
Excess weight can negatively impact ones physical and emotional well-being and can lead to an increased risk of developing metabolic syndrome, cardiovascular health issues, insulin resistance, and type 2 diabetes
TanTrap Dear valued customer Thank you for taking the time to leave us an excellent 5-star review
Semaglutide: Targets the brain centers that regulate appetite, especially after eating, which may help you eat less
Learn more Tesofensine Therapy Oral triple reuptake inhibitor that reduces appetite and boosts metabolism through a different pathway